Intellia Therapeutics (NTLA)
(Delayed Data from NSDQ)
$22.44 USD
-0.56 (-2.43%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $22.44 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 32% (81 out of 250)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.52 | 1.37 | 9.99 |
Current Quarter Estimate | -1.38 | 2.92 | 61.00 |
Year Ago Quarter Estimate | -1.38 | -4.86 | 54.84 |
Next Quarter Estimate | -1.44 | 3.90 | 63.00 |
Next Year Estimate | -5.46 | 25.15 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -0.37 | 18.00 | 15.67 |
Next Year | -0.37 | 9.30 | 11.34 |
Last 5 Years | -288.60 | 0.90 | 8.10 |
Next 5 Years | 1.10 | 21.60 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -6.80 |
Price/Book (MRQ) | 2.35 | 2.09 |
Price/Cash Flow (MRFY) | NA | 17.39 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | NA | -147.72% |
Return on Equity (TTM) | -47.12% | -60.38% |
Debt to Equity (MRQ) | 0.00 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.